The SVB H1 2026 State of Markets Report: A Venture Rebound With an Asterisk

Silicon Valley Bank's H1 2026 State of the Markets report landed with a broadly positive headline: nearly $340 billion invested in 2025, the best exit environment since 2021, and a venture market SVB describes as rebounding. 

The Top-Line Numbers

US VC-backed tech IPOs rose to 21 in H1 2026, the most since 2021. Half of US VC-backed tech unicorns now exceed $800 million in revenue, easily clearing the $400 million benchmark that historically precedes a public listing. SVB's report notes that 75% of all venture-backed tech companies are growing revenue, with 63% of those either profitable or improving profitability, and the percentage of profitable companies has more than doubled since 2022. The exit environment has genuinely improved.

The top 1% of venture deals captured one-third of all 2025 VC investment, while the bottom half received only 7%. AI categories contributed 10% to 30% of quarterly US GDP growth while representing under 4% of GDP. AI startups raised $560 billion since 2022, with the top five AI companies reaching over $1.2 trillion in combined value, three times all dot-com era IPO value combined. SVB's own framing: "fewer deals, bigger checks and conviction concentrated at the very top." The report's authors describe the current moment as surgical: if 2021 was about velocity and 2022 to 2023 was about triage, 2026 is about precision targeting at the apex while the rest of the market operates on fundamentally different terms.

The Unicorn Revenue Story

Half of US VC-backed tech unicorns exceeding $800 million in revenue is the most practically useful finding for investors evaluating the exit backlog. Two years ago, the primary concern was that unicorn valuations were paper numbers without the revenue to support public listings. The SVB data shows that concern has materially eased, at least for the upper half of the cohort.

The counterweight: the companies driving that revenue growth are disproportionately AI companies, and the companies approaching IPO readiness are disproportionately the same dozen names absorbing most of the capital. SVB warned that if SpaceX, OpenAI, and Anthropic take up all available capital in their public listings, a broader recovery could slip into 2027, further straining an already difficult liquidity environment for the rest of the market.

The healthcare data adds texture here. SVB's separate Healthcare Investments and Exits H1 2026 report shows healthcare VC in an AI surge amid a fundraising slump, with healthtech attracting more investment than any other healthcare sector, almost entirely driven by AI-enabled solutions in provider operations. The pattern is identical to the broader market: AI subsectors within any vertical are capturing capital that would previously have been distributed more broadly across the category.

The Fundraising Paradox

US VC fundraising fell to $60 billion, a seven-year low, even as tech IPOs rose to their highest level since 2021 and AI investment set records. Record AI investment alongside a fundraising drought for VC managers reflects the same concentration dynamic from a different angle: capital is flowing into AI companies at unprecedented scale, but directly from sovereign wealth funds, hyperscalers, and large crossover investors rather than through traditional VC fund structures. The managers raising new funds are competing for LP capital that has been partially redirected into direct AI investments at the top of the market.

SVB notes that 63% of capital raised by $1 billion-plus funds in 2022 has been deployed, suggesting those large platforms are coming back to market, but primarily for mega-fund vehicles that can write mega-checks. For first-time fund managers and smaller generalist funds, this is a structural headwind the positive investment headlines obscure. SVB's framing of "specialisation as the winning strategy" reflects it: the funds that are raising are the ones with a clear differentiated thesis, not broad-based mandates.

Q1 2026 European venture investment hit $17.6 billion, up 30% year-on-year, with AI reaching 50% of EU VC funding for the first time. The same bifurcation is playing out globally: AI absorbs more than half of total funding, non-AI categories compete for the rest, and the fundraising drought for non-AI-focused managers is a feature of the market structure rather than a temporary cyclical dip.

What "Surgical" Actually Means for Founders

SVB's bifurcation framing has a practical implication for companies raising outside the AI consensus: the bar is what it was in 2017 with an extra step. Partners are saying no to more pitches, faster. Q1 2026 deal-count compression means the venture market in 2026 is the most bifurcated it has been in a decade, and companies without a clear AI angle or platform-level differentiation are competing for a smaller pool of capital with a higher diligence bar.

The counterintuitive opportunity SVB identifies is in the 67% of US VC dollars outside the top 1% of companies. For investors willing to look at underfollowed sectors with discipline, the absence of competition creates conditions for better entry prices and more differentiated returns. This is the same argument Wellington Management made in their midyear outlook, which we covered in our piece on private markets concentration: the concentration at the top is creating less efficient segments below, and that inefficiency is an opportunity for investors with a different mandate.

The Exit Backlog Is Not Clearing Evenly

The annualised pace of VC-backed IPOs in 2026 remains well short of what is needed to meaningfully reduce the years-long backlog, according to PitchBook. The upper tier is clearing: unicorns with $800 million or more in revenue and clear paths to profitability are approaching the window. The middle of the distribution (companies with $100 to $400 million in revenue, reasonable growth but no AI story, and 2021 valuations that have not been marked down) remains in a more difficult position.

The SVB data and the PitchBook backlog concern are both accurate; they describe different parts of the same market. Our piece on the PitchBook Q2 2026 Venture Monitor covers the concentration data in detail.

NonPublic Pty Ltd (ABN 49 607 216 928) holds Australian Financial Services Licence #482668. Investments are available to wholesale and sophisticated investors as defined under the Corporations Act 2001. This content is general in nature and does not constitute financial product advice. It does not take into account your objectives, financial situation, or needs. Investing in private markets involves significant risk, including the potential loss of your entire investment. Past performance is not a reliable indicator of future results. You should obtain independent financial advice before making any investment decision.